136 related articles for article (PubMed ID: 29480027)
1. Transcriptomic and epigenetic analysis of breast cancer stem cells.
Li G; Wang D; Ma W; An K; Liu Z; Wang X; Yang C; Du F; Han X; Chang S; Yu H; Zhang Z; Zhao Z; Zhang Y; Wang J; Sun Y
Epigenomics; 2018 Jun; 10(6):765-783. PubMed ID: 29480027
[TBL] [Abstract][Full Text] [Related]
2. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
[TBL] [Abstract][Full Text] [Related]
3. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
6. The epigenome of AML stem and progenitor cells.
Yamazaki J; Estecio MR; Lu Y; Long H; Malouf GG; Graber D; Huo Y; Ramagli L; Liang S; Kornblau SM; Jelinek J; Issa JP
Epigenetics; 2013 Jan; 8(1):92-104. PubMed ID: 23249680
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
8. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
11. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
12. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
[TBL] [Abstract][Full Text] [Related]
14. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.
Lim YY; Wright JA; Attema JL; Gregory PA; Bert AG; Smith E; Thomas D; Lopez AF; Drew PA; Khew-Goodall Y; Goodall GJ
J Cell Sci; 2013 May; 126(Pt 10):2256-66. PubMed ID: 23525011
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and metabolic regulation of breast cancer stem cells.
Liu HX; Li XL; Dong CF
J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
[TBL] [Abstract][Full Text] [Related]
17. Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.
Messier TL; Boyd JR; Gordon JA; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2016 Nov; 231(11):2474-81. PubMed ID: 26916849
[TBL] [Abstract][Full Text] [Related]
18. The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells.
Zhao Z; Li S; Song E; Liu S
Protein Cell; 2016 Feb; 7(2):89-99. PubMed ID: 26349457
[TBL] [Abstract][Full Text] [Related]
19. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.
Xi Y; Shi J; Li W; Tanaka K; Allton KL; Richardson D; Li J; Franco HL; Nagari A; Malladi VS; Coletta LD; Simper MS; Keyomarsi K; Shen J; Bedford MT; Shi X; Barton MC; Kraus WL; Li W; Dent SYR
BMC Genomics; 2018 Feb; 19(1):150. PubMed ID: 29458327
[TBL] [Abstract][Full Text] [Related]
20. Radioresistant breast cancer cells exhibit increased resistance to chemotherapy and enhanced invasive properties due to cancer stem cells.
Ko YS; Jin H; Lee JS; Park SW; Chang KC; Kang KM; Jeong BK; Kim HJ
Oncol Rep; 2018 Dec; 40(6):3752-3762. PubMed ID: 30272295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
